Wikipedia

Bacteriophage AP205

Bacteriophage AP205 is a plaque-forming bacteriophage that infects Acinetobacter bacteria.[1][2] Bacteriophage AP205 is a protein-coated virus with a positive single-stranded RNA genome. It is a member of the family Fiersviridae, consisting of particles that infect Gram-negative bacteria such as E. coli.[3]

Bacteriophage AP205
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Lenarviricota
Class: Leviviricetes
Order: Norzivirales
Family: Duinviridae
Genus: Apeevirus
Species:
Apeevirus quebecense
Virus:
Acinetobacter phage AP205

AP205 was isolated from the gram negative species Acinetobacter.[4] Sewage from Quebec, Canada was scanned for bacteriophages that replicated in Acinetobacter bacteria. AP205 was isolated by enrichment methods from urine by P. J. M. Bouvet.[4] The virus was attached to a pili of Acinetobacter. Using electron microscopy, researchers were able to describe the physical characteristics of AP205.[4]

Structure

edit
 
Structure of an ssRNA bacteriophage

The main structural component of Bacteriophage AP205 in the Fiersviridae family is a protein shell. Viruses in this family are not enveloped and are characterized by their icosahedral and spherical shape. The icosahedron shape of the capsid results from the arrangement of 178 copies of the coat protein which provide the virus with its structure. While the virus is icosahedral, the surface protrusions are smoother and less prominent of other viruses, giving the capsid a spherical appearance. The coat proteins form dimeric interactions due to hydrophobic and polar interactions to provide the capsid with a high level of structural rigidity.[3] Before forming these dimers, the coat protein exists in three monomeric conformations, labeled A, B, and C. The A and C subunits of the capsid are folded in an arrangement such that they form a three-fold axis while the B subunit is arranged to form a five-fold axis . The protein shell also includes a single copy of a maturation protein (A protein) that functions in maturation of the virus and pilus attachment in prokaryotes.[3] The virus-like particle (VLP) formation without the maturation protein consists of 60 dimers, 30 of which are made of the subunits A and B. The remaining dimers are "CC dimers", forming a homodimer. The maturation protein replaces a CC dimer, resulting in 178 copies of the coat protein as opposed to the expected 180.[3] Identifying characteristics of the Leviviridae coat proteins include a β-hairpin at the N-terminus, a β-sheet with five strands, and two α-helices at the C-terminus.[3] Bacteriophage AP205 has many secondary protein structures, which contributes to its structural rigidity. The capsid self-assembles in vitro.[5] AP205 is 29 nanometers in diameter, making it one of the largest Fiersviridae viruses known as this time.[citation needed]

Genome

edit

Bacteriophage AP205 contains a (+) sense single stranded RNA genome.[3] The genome length for single stranded RNA phages are short, including that of Bacteriophage AP205. However, the genome of AP205 is longer than other Fiersviridae, containing approximately 4268 nucleotides with coding regions for a lytic protein, maturation protein, coat protein, and an RNA-dependent RNA polymerase.[6][4] The AP205 genome is longer than most single stranded RNA phages due to the presence of lengthy intercistronic regions, a long maturation gene, and two extra open reading frames before the maturation sequence.[4]

Operator

edit

The operator of AP205 contains a 4 nucleotide loop with adenosine at the first and last position with two other amino acids in between. This loop is typically present in the operator region of Fiersviridae.[4] The AP205 operator region has a bulged adenosine on the hairpin structure similar to viruses in the Qubevirus genera. However, it is positioned closer to the 3' end of the hairpin structure.[4]

Lytic gene

edit

The first open reading frame (ORF) codes for a short lysis gene containing 35 amino acids.[7] This gene is in a different position from the lytic genes of other viruses related to AP205.[2] While other Fiersviridae encode their lytic genes between the coat and replicase proteins, AP205 has an open reading frame encoding a functional protein toward the 5' end of the genome that researchers suspect to have lytic function.[4][8] The N-terminus of the gene consists of positively charged amino acids. The C-terminus consists of a group of non-polar amino acids. To confirm the function of the protein, researchers cloned the gene into a plasmid with a strong promoter. The plasmid was induced in E. coli, which resulted in limited cell growth when compared to the control. The enzymes encoded by the lysis protein do not disrupt the proton motive force of the host cell.[4] This supports the theory that AP205 bacteriophage evolved and formed a lysis gene through utilizing a vacant area of the genome.[4] The lytic protein of AP205 is produced in an efficient manner, and is used to lyse bacteria other than the host cell.[8]

Maturation gene

edit

Researchers suspect that the second open reading frame is involved in the translation of the maturation gene. Independent translation from the start codon of the second reading frame is suppressed by the lack of a strong Shine-Dalgarno sequence and a stable hairpin structure. The start codon of this ORF is within this strong hairpin secondary structure.[4] The hairpin structure results in a translational rephrasing from the ORF2 reading frame to the A-protein (maturation protein) frame.[4] The protein product of the maturation gene facilitates attachment of the bacteriophage to the host pilus through the cell attachment motif.[4][9]

Coat protein gene

edit
 
3D Structure of a Bacteriophage AP205 Coat Protein

The third ORF codes for the coat protein. The coat protein of AP205 varies from other single stranded RNA phages due to the presence of a C-terminal β-strand that is not seen in evolutionarily related particles.[3] In every other known single stranded RNA bacteriophage, the first twenty amino acid of the coat protein form two β-strands (strands A and B) that combine and yield a β-hairpin on the exterior surface of the viral particle.[3] In AP205, the first β-strand (strand A) of the coat protein is located at the same position as the second strand (strand B) in other phages. However, the C-terminal strand (strand B) in AP205 coincides with the first strand (strand A). The termini connect via an amino acid linker and yield a dimer, which serves as the subunit for capsid assembly.[3][10] When dimerized, the C-terminus of one coat protein monomer is located close to the N-terminus of the other. The AP205 coat protein transfers the N-terminal β-strand strand to the C-terminus to yield circular permutation of the capsid. The result of this conformation is a lack of an AB loop formed by Strand A and B.[3] The topology of the AP205 coat protein dimer resembles the double sandwich model of other ssRNA phages. The helices of AP205 form a wide gap that is filled with large side chains.[3] The wider gaps result from a long αA subunit and the wide angle of which the αB subunit is to the αA subunit and the β-sheet.[3] The space provided by the gaps is utilized by bulky side chains. The coat protein follows the conserved folding pattern of Fiersviridae with the exception of β-hairpin formation at the N-terminus.[3]

Replicase gene

edit

The final ORF encodes the replicase gene. The protein product of this sequence yields a RNA-dependent RNA polymerase. The replicase gene is controlled by the same mechanism in all single stranded RNA bacteriophages. The start codon is folded into a hairpin structure with an affinity for the coat protein. However, in AP205 there is no binding of the coat protein to the translational operator of the replicase gene to repress translation.[11]

 
The genomic RNA of Bacteriophage AP205 is synthesized using a viral RNA-dependent RNA polymerase encoded in the replicase gene.

Taxonomy

edit

Single stranded RNA viruses are subject to higher levels of mutation when compared to other viruses, resulting in a diverse collection of genomic sequences.[3] Single stranded RNA coliphages are classified into two genera: Qubevirus and Fiersviridae. AP205 shares characteristics with viruses in both of these genera (such as the Fiersviridae MS2 and the Quebevirus Qβ),[4] and is phylogenetically classified between MS2 and Qβ. The operator region of displays identifying cahracteristics of both genera. The operator in AP205 has adenosine residues are in the same placement as those in Fiersviridae, but there is not a bulged adenosine at the same position of the hairpin loop in the operator.[4] Viruses in the Quebevirus genera encode a coat extension protein, which the Fiersviridae genera lacks. AP205 does not contain this coat extension protein.[4] AP205 has more genetic similarities to Fiersviridae, with the exception of the 3' UTR which has more similarities to a Quebevirus.[4] There are many conserved sequences and motifs in AP205 that aide in the phylogenetic classification of the bacteriophage. The sequence UGCUU in the 3' untranslated region is preserved in all RNA coliphages, and is present in AP205.[4] The RNA-dependent RNA polymerases of AP205 contain the conserved (Y)GGD motif present in other positive sense single stranded RNA bacteriophages.[4]

Infection

edit
 
Bacteriophage AP205 is a lytic phage. Upon infection of a bacterium, the following cycle is completed within the host.

Bacteriophage AP205 infects gram-negative bacteria by attaching to and adsorbing into the pilus of the Acinetobacterium. The maturation protein recognizes the pilin subunits of the host’s pilus.[12] AP205 uses type IV twitching pili for attachment to the host cell.[7][13] Once bound to the pilus, the virus releases its genome into the bacteria by cleaving the maturation/A protein.[6] During the later stages of infection in single stranded RNAs, the coat protein will bind to an RNA hairpin structure preceding the replicase gene. AP205 is an exception, and does not experience this type of interaction.[14] In other single stranded RNA phages, a high concentration of the coat protein results in the binding of a dimer to the hairpin loop, which blocks ribosomal access.[4] This halts transcription of the replicase protein, and results in packaging of the replicated viral genome.[3] Further research is necessary to determine the termination of replicase translation. After the coat proteins are produced, the capsid experiences self-assembly.[8] Circular permutation exposes the exterior termini on the coat proteins, which cluster together through various interactions.[8] Once assembled, the virus will lyse the cell via the product of the lytic gene. The single-gene lysis mechanism of AP205 is unknown. However, the product of the lysis gene‘ in many single stranded RNA bacteriophages does not have any peptidoglycan degradation ability.[12]

Medical applications

edit

Modular vaccine approach

edit

The capsid of AP205 has 180 protein subunits. Each individual subunit can be fused to multiple peptides. Researchers have made an AP205 VLP with up to  370 peptides attached to the coat.[15] The lack of an AB loop in AP205 provides an advantage to using the VLP in the development of vaccines. Peptide insertions to the area can destabilize the protein shell of the VLP and yield nonfunctional dimers.[3] Bacteriophage AP205 has been used as a vector for delivering antigens in vaccines.[3] The production of virus-like particles (VLP) derived from Bacteriophage AP205 can be used to display antigens that elicit an immune response in the target. Using a VLP as a vector for immunization does not pose a risk of transmitting disease due to the absence of a viral genome.[16] AP205 serves as an attractive virus for this process due to its high tolerance for antigen fusion. The coat protein of an AP205 VLP can tolerate conjugation to many antigens due to the availability of both the N and C terminus. This availability of both termini is a limiting factor in the use of other VLPs in immunological studies.[17] AP205 VLPs are also used in vaccine designs due to their ability to self-assemble with long epitopes up to 55 amino acids in length fused to the surface. These structures activate a strong humoral response through production of specific antibodies in the host [9]. Bacteriophage AP205 has been used in previous studies to produce vaccines-induced active active immunity against SARS-CoV-2, Influenza, West Nile Virus, HIV, and many other infectious viruses.[citation needed]

Influenza

edit

Bacteriophage AP205 has been used to make vaccines for influenza. By fusing the M2e extracellular domain of the influenza virus to the capsid of a AP205 VLP, researchers have been able to produce vaccines described to have protected infected mice from a lethal dosage of influenza.[18] Researchers have fused the consensus sequence of the antigenic influenza M2e protein to the N-terminus of the capsid protein of AP205 by using a linker sequence. The VLP was propagated in E. coli. The genomic content within the M2e-AP205 VLP may be contaminated with RNA from the E. coli which the VLPs were propagated in, leading to induction of various antibodies that were not induced against the M2e.[18] Mice immunized with M2e-AP205 that contained RNA from E. coli displayed more protection when compared to the mice immunized with M2e-AP205 that did not contain the RNA. These results indicate that the RNA within the VLP plays a role in the immunity provided against influenza.[18]

Angiotensin II Receptor Type 1

edit

Researchers have used AP205 VLP to decrease blood pressure in hypertensive animal subjects. They produced a vaccine through conjugating the B cell epitope ATR001 to the AP205 capsid protein structure.[19] The repetitive pattern of the ATR001 epitopes permitted the formation of immune complexes with IgM antibodies following exposure. In addition to activating humoral immunity in vivo, the  ATR-AP205-001 vaccine resulted in enhanced differentiation of Tfh cells, leading to expression of proinflammatory cytokines such as IL-21.[19] IL-21 is required for the activation of memory B cells that are specific to the ATR001 epitope.[19][20] The ATR-AP205-001 vaccine resulted in a rapid humoral response initiated through the recruitment of dendritic cells, Tfh cells, and B cells with limited activation from regulatory T cells.[19][21]

SARS-CoV-2

edit

Research studies have concluded that Bacteriophage AP205-VLPs can be used to generate a vaccine against SARS-CoV-2.[22] Using the coat proteins of AP205, researchers have been able to present the receptor binding domain of the SARS-CoV-2 spike protein to invoke an immune response in mice.[23] A stable AP205 VLP was designed by using a linker to fuse 2 capsid proteins, then adding the receptor binding motif (RBM) domain of the SARS-CoV-2 spike to the C terminus of the AP205 dimer.[22] The formation of this complex was confirmed via SDS-PAGE and Electron Microscopy analysis. Each dimer in the AP205 VLP incorporated a RBM domain, resulting in 90 RBM domains per VLP. Mice immunized with the AP205-RBM experienced an increase in IgA response, RBD and spike protein specific antibody production, and class switching to IgG2a and IgG1 antibodies that was not observed in the control subjects.[22] Researchers have also used SpyCatcher to fuse the RBD proteins to the capsid of an AP205VLP.[23] To form a RBD-CLP particle, researchers fused a peptide-binding Tag and a gene linker to the N-terminus AP205 coat protein, which was then cloned into the pET28a(+) vector. The plasmid was transformed into competent E. coli cells, and the subsequent Tag-CLP products were  purified.[23] Researchers fused receptor binding domain antigens with a GSGS linker and the split-protein Catcher, and combined this product with the Tag-CLP to form RBD-CLP complexes. Mice immunized with this complex displayed induction of IgG2a and IgG2b antibodies.[23]

West Nile virus

edit

Cross-linking an antigen to the surface of a AP205 VLP can increase the immunogenicity of the protein.[24] Vaccines made via the conjugation of DIII to AP205 VLPs induced high titers of antibodies specific to DIII after a single injection when compared to the groups of mice who were immunized with free DIII-C proteins and non-conjugated AP205 particles.[25] The repetitive pattern of DIII on the capsid results in efficient cross-linking of B-Cell Receptors and leads to a specific humoral response in the host. Antigen presenting cells uptake the VLP, present the DIII antigen epitopes on the MHC II receptor to activate T helper cells.[25] Bacterial RNA packaged within the BLP enhances antigen-presenting cell activity when it is delivered to the endosomal compartment and activates TLR 3 and TLR7/8.[25] The AP205 subunits that were cross-linked to DIII-C molecules displayed an average of 50 DIII molecules per particle due to the availability of both the N and C terminus on the coat protein. The immunogenicity of the AP205 vaccine proved to be higher than the previous vaccines.[25] VLPs made in this experiment contained about 25-30 micrograms of host cell E. Coli RNA per 100 micrograms of coat protein. The antibodies produced act to neutralize the infectious West Nile Virus particles.[25]

Other applications

edit

Salmonid aquaculture

edit

Bacteriophage AP2-5 can be used to target pathogenic bacterium in animals as well as human hosts. Bacteriophage AP205 can be used to vaccinate fish against A. salmonicida, a gram negative bacterium found in salmon with furunculosis.[26] Research studies have used conjugated AP205 VLP-VapA to induce a strong antibody reaction in rainbow trout resulting in survival rates up to 44% higher than that of the control immunization.[16]

Agriculture and waste water treatment

edit

AP205 can be utilized as an indicator for microbial contaminants in water to reduce public health risks. While bacterial coliforms are usually used to determine contamination levels of water, viruses provide several advantages.[27] Viruses are typically more resistant  against UV radiation and other environmental stresses. AP205 shares a similar chemical composition and several physical characteristics similar to noroviruses and rotaviruses, allowing it to be used as a surrogate marker of contamination of crops by enteric viruses.[27] AP205 is propagated in Acinetobacter baumannii, which can cause gastroenteritis in individuals who consume contaminated produce.[28]

References

edit
  1. ^ Turner D, Ackermann HW, Kropinski AM, Lavigne R, Sutton JM, Reynolds DM (December 2017). "Comparative Analysis of 37 Acinetobacter Bacteriophages". Viruses. 10 (1): 5. doi:10.3390/v10010005. PMC 5795418. PMID 29295549.
  2. ^ a b Chamakura KR, Young R (August 2020). "Single-gene lysis in the metagenomic era". Current Opinion in Microbiology. 56: 109–117. doi:10.1016/j.mib.2020.09.015. PMC 7744336. PMID 33075663.
  3. ^ a b c d e f g h i j k l m n o p q Shishovs M, Rumnieks J, Diebolder C, Jaudzems K, Andreas LB, Stanek J, et al. (October 2016). "Structure of AP205 Coat Protein Reveals Circular Permutation in ssRNA Bacteriophages". Journal of Molecular Biology. 428 (21): 4267–4279. doi:10.1016/j.jmb.2016.08.025. PMID 27591890.
  4. ^ a b c d e f g h i j k l m n o p q r s t Klovins J, Overbeek GP, van den Worm SH, Ackermann HW, van Duin J (June 2002). "Nucleotide sequence of a ssRNA phage from Acinetobacter: kinship to coliphages". The Journal of General Virology. 83 (Pt 6): 1523–1533. doi:10.1099/0022-1317-83-6-1523. PMID 12029168.
  5. ^ Goldbourt A (October–December 2019). "Structural characterization of bacteriophage viruses by NMR". Progress in Nuclear Magnetic Resonance Spectroscopy. 114–115: 192–210. doi:10.1016/j.pnmrs.2019.06.004. PMID 31779880. S2CID 198332585.
  6. ^ a b "Leviviridae | ICTV". ictv.global. Retrieved 2023-11-01.
  7. ^ a b Rumnieks J, Tars K (November 2012). "Diversity of pili-specific bacteriophages: genome sequence of IncM plasmid-dependent RNA phage M". BMC Microbiology. 12 (1): 277. doi:10.1186/1471-2180-12-277. PMC 3561173. PMID 23176223.
  8. ^ a b c d Unclear source. One of the following:
  9. ^ Friedman SD, Genthner FJ, Gentry J, Sobsey MD, Vinjé J (November 2009). "Gene mapping and phylogenetic analysis of the complete genome from 30 single-stranded RNA male-specific coliphages (family Leviviridae)". Journal of Virology. 83 (21): 11233–11243. doi:10.1128/JVI.01308-09. PMC 2772794. PMID 19710143.
  10. ^ Peabody DS, Lim F (June 1996). "Complementation of RNA binding site mutations in MS2 coat protein heterodimers". Nucleic Acids Research. 24 (12): 2352–2359. doi:10.1093/nar/24.12.2352. PMC 145953. PMID 8710507.
  11. ^ Liekniņa I, Kalniņš G, Akopjana I, Bogans J, Šišovs M, Jansons J, et al. (May 2019). "Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data". Journal of Nanobiotechnology. 17 (1): 61. doi:10.1186/s12951-019-0497-8. PMC 6513524. PMID 31084612.
  12. ^ a b Chamakura KR, Young R (August 2020). "Single-gene lysis in the metagenomic era". Current Opinion in Microbiology. Microbe – Microbe Interactions • Microbiota. 56: 109–117. doi:10.1016/j.mib.2020.09.015. PMC 7744336. PMID 33075663.
  13. ^ Chamakura K, Young R (March 2019). "Phage single-gene lysis: Finding the weak spot in the bacterial cell wall". The Journal of Biological Chemistry. 294 (10): 3350–3358. doi:10.1074/jbc.TM118.001773. PMC 6416421. PMID 30420429.
  14. ^ Tars K (2020). "SsRNA Phages: Life Cycle, Structure and Applications". Biocommunication of Phages. Cham: Springer International Publishing. pp. 261–292. doi:10.1007/978-3-030-45885-0_13. ISBN 978-3-030-45884-3. S2CID 220266403.
  15. ^ Pastori C, Tudor D, Diomede L, Drillet AS, Jegerlehner A, Röhn TA, et al. (September 2012). "Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41". Virology. 431 (1–2): 1–11. doi:10.1016/j.virol.2012.05.005. PMID 22658900.
  16. ^ a b Yang JI, Sepúlveda D, Vardia I, Skov J, Goksøyr L, Sander AF, Lorenzen N (2023). "High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout". Frontiers in Immunology. 14 (1139206): 1139206. doi:10.3389/fimmu.2023.1139206. PMC 10239931. PMID 37283749.
  17. ^ Liekniņa I, Černova D, Rūmnieks J, Tārs K (August 2020). "Novel ssRNA phage VLP platform for displaying foreign epitopes by genetic fusion". Vaccine. 38 (38): 6019–6026. doi:10.1016/j.vaccine.2020.07.016. PMID 32713683. S2CID 220796212.
  18. ^ a b c Schmitz N, Beerli RR, Bauer M, Jegerlehner A, Dietmeier K, Maudrich M, et al. (April 2012). "Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection". European Journal of Immunology. 42 (4): 863–869. doi:10.1002/eji.201041225. PMID 22531913. S2CID 30439010.
  19. ^ a b c d de Rham C, Ferrari-Lacraz S, Jendly S, Schneiter G, Dayer JM, Villard J (2007). "The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors". Arthritis Research & Therapy. 9 (6): R125. doi:10.1186/ar2336. PMC 2246246. PMID 18053164.
  20. ^ Spolski R, Leonard WJ (May 2014). "Interleukin-21: a double-edged sword with therapeutic potential". Nature Reviews. Drug Discovery. 13 (5): 379–395. doi:10.1038/nrd4296. PMID 24751819. S2CID 15179314.
  21. ^ Crotty S (October 2014). "T follicular helper cell differentiation, function, and roles in disease". Immunity. 41 (4): 529–542. doi:10.1016/j.immuni.2014.10.004. PMC 4223692. PMID 25367570.
  22. ^ a b c Liu X, Chang X, Rothen D, Derveni M, Krenger P, Roongta S, et al. (April 2021). "AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate". Vaccines. 9 (4): 403. doi:10.3390/vaccines9040403. PMC 8073683. PMID 33921677.
  23. ^ a b c d Fougeroux C, et al. (2021). "Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity". Nature Communications. 12 (1): 324. Bibcode:2021NatCo..12..324F. doi:10.1038/s41467-020-20251-8. hdl:1887/3230190. PMC 7804149. PMID 33436573.
  24. ^ Zepeda-Cervantes J, Ramírez-Jarquín JO, Vaca L (2020-06-09). "Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs". Frontiers in Immunology. 11: 1100. doi:10.3389/fimmu.2020.01100. PMC 7297083. PMID 32582186.
  25. ^ a b c d e Spohn G, Jennings GT, Martina BE, Keller I, Beck M, Pumpens P, et al. (July 2010). "A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice". Virology Journal. 7 (1): 146. doi:10.1186/1743-422X-7-146. PMC 2914671. PMID 20604940.
  26. ^ Tewari R, Dudeja M, Nandy S, Das AK (February 2014). "Isolation of Aeromonas salmonicida from Human Blood Sample: A Case Report". Journal of Clinical and Diagnostic Research. 8 (2): 139–140. doi:10.7860/JCDR/2014/6883.4032. PMC 3972533. PMID 24701507.
  27. ^ a b Summerlin HN, Pola CC, Chamakura KR, Young R, Gentry T, McLamore ES, et al. (2021-08-24). "Fate of enteric viruses during leafy greens (romaine lettuce) production using treated municipal wastewater and AP205 bacteriophage as a surrogate". Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering. 56 (10): 1138–1144. Bibcode:2021JESHA..56.1138S. doi:10.1080/10934529.2021.1968231. PMID 34427159. S2CID 237282172.
  28. ^ Malta RC, Ramos GL, Nascimento JD (September 2020). "From food to hospital: we need to talk about Acinetobacter spp". Germs. 10 (4): 210–217. doi:10.18683/germs.2020.1207. PMC 7572206. PMID 33134199.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bacteriophage_AP205&oldid=1229712707"